SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-021904
Filing Date
2022-11-03
Accepted
2022-11-03 16:22:59
Documents
56
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q tlis-20220930.htm   iXBRL 10-Q 2771059
2 EX-31.1 tlis-ex31_1.htm EX-31.1 21490
3 EX-31.2 tlis-ex31_2.htm EX-31.2 23054
4 EX-32.1 tlis-ex32_1.htm EX-32.1 13307
5 EX-32.2 tlis-ex32_2.htm EX-32.2 14867
  Complete submission text file 0000950170-22-021904.txt   8208626

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT tlis-20220930_cal.xml EX-101.CAL 36632
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT tlis-20220930.xsd EX-101.SCH 49553
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT tlis-20220930_pre.xml EX-101.PRE 344087
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT tlis-20220930_lab.xml EX-101.LAB 468051
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT tlis-20220930_def.xml EX-101.DEF 226852
50 EXTRACTED XBRL INSTANCE DOCUMENT tlis-20220930_htm.xml XML 1198855
Mailing Address 3400 BRIDGE PARKWAY REDWOOD CITY CA 94065
Business Address 3400 BRIDGE PARKWAY REDWOOD CITY CA 94065 650-433-3000
Talis Biomedical Corp (Filer) CIK: 0001584751 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40047 | Film No.: 221358397
SIC: 3826 Laboratory Analytical Instruments